NICE backs biosimilars with arthritis drug endorsements

January 27, 2016
Research and Development, Sales and Marketing DMARDs, NICE, biosimilars, rheumatoid arthritis

NICE has published updated final guidance recommending seven biological disease modifying drugs (DMARDs) for treatment of severe rheumatoid arthritis which …

Amgen image

FDA to review Amgen’s Humira biosimilar

January 26, 2016
Manufacturing and Production ABP-501, Amgen, FDA, biosimilar

The FDA has accepted for review Amgen’s Biologics License Application (BLA) for ABP 501, a biosimilar candidate to AbbVie’s Humira …

Middle east

Post-sanctions Iran attracts pharma investment

January 26, 2016
Manufacturing and Production, Sales and Marketing Gulf Co-operation Council, Iran, Isral, Saudi Arabia, United Arab Emirates, middle east

Just a few days have passed since decade-long economic sanctions on Iran were lifted, as the middle-eastern powerhouse agreed to …

Mosquito image

GSK and Sanofi considering developing Zika vaccine

January 26, 2016
Manufacturing and Production GSK, Sanofi, World Health Organisation, Zika virus, microcephaly

Pharma companies Sanofi and GSK are reviewing the possibility of using their respective inoculation technologies to develop a vaccine for …

pharmacy Senegal

UK Government commits £1 billion to malaria fight

January 26, 2016
Manufacturing and Production Bill Gates, Chancellor, George Osborne, Ross Fund, infectious diseases, malaria

Chancellor George Osborne has set out details of a billion pound fund to develop, test and produce new products to …

shire_image

Shire tries again with lifitegrast dry eye FDA application

January 25, 2016
Manufacturing and Production, Sales and Marketing FDA, Shire, dry eye disease, lifitegrast

Shire has resubmitted its New Drug Application (NDA) to the US FDA for its rejected dry eye syndrome drug lifitegrast. …

philippe_cotrel

Avacta appoints Philippe Cotrel as chief commercial officer

January 25, 2016
Manufacturing and Production, Research and Development Avacta

Cotrel joins Avacta from Abcam, where he held the role of commercial operations director.He will lead the Group’s commercial strategy …

matthewpfeffer_sm

New chief exec at MannKind

January 25, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Alfred Mann, Duane DeSisto, Insulet, Mannkind, Matthew Pffefer

The board of directors of MannKind have appointed Matthew Pfeffer as chief executive of MannKind.He replaces Alfred Mann who has …

AbbVie VP joins UCB Pharma

January 25, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Pascale Richetta, UCB, UCB Pharma

Pascale Richetta will join the UCB as its new head of the bone therapy patient value unit as from February …

bruce_ponder

Cancer Research UK appoints Professor Sir Bruce Ponder as trustee

January 25, 2016
Research and Development Cancer Research UK, Professor Sir Bruce Ponder

Cancer Research UK has appointed Professor Sir Bruce Ponder as a trustee. Ponder is emeritus professor of oncology at Cambridge …

Amgen earns first Japanese nod for PCSK9 inhibitor

January 25, 2016
Sales and Marketing Amgen, Astellas, Japan, PCSK9 inhibitor, Repatha, evolocumab, high cholesterol

The Japanese Ministry of Health, Labour and Welfare has approved Amgen’s cholesterol-lowering medication Repatha, in a joint venture between Amgen …

careers

The case for leaders with scientific acumen in pharma

January 25, 2016
Medical Communications, Research and Development research and development

Pharmaceutical companies are currently undergoing fundamental, disruptive changes to conventional research and development models. This is in an attempt to …

Researcher

Big pharma and UK universities launch £40m innovation fund

January 25, 2016
Research and Development, Sales and Marketing Apollo, AstraZeneca, GSK, GlaxoSmithKline, Johnson & Johson, UCL, University College London, University of Cambridge, collaboration, imperial college london, joint venture

A consortium of big pharma companies and university with world-leading medical research facilities is to invest £40 million, to “significantly …

TTP flags

Researchers raise TPP legislation concerns

January 25, 2016
Manufacturing and Production, Sales and Marketing Legislation, Trans-Pacific Partnership, tpp, trade agreement

Academics have warned that global trade regulations under consideration by the US and other countries could prevent access to medicines …

FDA building

FDA approves new uses for BMS’ Opdivo/Yervoy cancer combo

January 25, 2016
Sales and Marketing BMS, Bristol-Myers Squibb, Yervoy, ipilimumabm melanoma, nivolumab, opdivo, skin cancer

The FDA has granted Bristol Myers Squibb an expanded indication for its two-cancer drug regimen Opdivo and Yervoy, to treat …

AbbVie

AbbVie and MD Anderson in cancer research partnership

January 25, 2016
Research and Development, Sales and Marketing AbbVie, MD Anderson Cancer Centre, immuno-oncology

AbbVie has announced a new partnership with The University of Texas MD Anderson Cancer Centre, using its immunotherapy platform to …

J&J image

Patients sue J&J for $800m for ‘hiding antibiotic side effects’

January 22, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Janssen, Johnson and Johnson, Levaquin, Margaret Hamburg, lawsuit, levofloxacin

Six users of Johnson & Johnson’s antibiotic Levaquin are to sue the company for up to $870 million, claiming the …

Proteus system

California hospital becomes first to prescribe digital pill

January 22, 2016
Medical Communications california, digital health, digital pill, ingestible pill, proteus

Proteus Digital Health, the first company to have a ‘digital pill’ approved by the FDA, has signed its first deal …

Amgen image

FDA approves new Kyprolis combo for multiple myeloma

January 22, 2016
Medical Communications, Sales and Marketing Amgen, FDA, Kyprolis, carfilzomib, multiple myeloma, myeloma

Amgen’s Kyprolis has been given another endorsement by the FDA as a multiple myeloma treatment – its second in six …

j

Merck appoints Jessie English to lead discovery team

January 22, 2016
Research and Development Jessie English, Merck

Merck has appointed Jessie English as the new vice president of discovery, translational innovation platform immuno-oncology, effective February 16, 2016. …

The Gateway to Local Adoption Series

Latest content